Tetralogy of Fallot (TOF) in Adults Workup: Approach Considerations, Imaging Studies

Sections

Sections Tetralogy of Fallot (TOF) in Adults
Overview
Presentation
DDx
Workup
Treatment
Guidelines
Medication
Questions & Answers
Media Gallery
References

Workup

Approach Considerations

See also the Guidelines section for the 2018 American Heart Association/American College of Cardiology (AHA/ACC) recommendations for the management of adults with tetralogy of Fallot.

Laboratory studies

Laboratory studies that may be helpful in the evaluation of adult patients with tetralogy of Fallot (TOF) include the following:

Complete blood cell (CBC) count: Some patients may have a mild anemia, but if cyanosis is absent, polycythemia is rare.
Coagulation profile: This may be abnormal in patients with cyanosis and bleeding.
Arterial blood gas (including serum lactate, base excess, oxygen partial pressure [PO₂]): The patient's oxygenation status, serum lactate levels, and base excess value appear to be prognostic markers for mortality in those undergoing surgical repair of tetralogy of Fallot.^[4]
Blood cultures: Obtain blood cultures in febrile patients to rule out endocarditis or sepsis.

Electrocardiography

The electrocardiogram (ECG) will usually show the presence of right ventricular (RV) hypertrophy with a right bundle branch block. The longer the QRS interval, the larger will be the RV mass and volume. Furthermore, when the QRS interval is longer than 180 milliseconds (ms), it is a significant marker for the development of ventricular arrhythmias and sudden death.^[22]

Another ECG feature that is also known to predict the risk for ventricular arrhythmias and sudden death is the rate of change in the QRS interval. A relatively fast increase (>3.5 ms/year) is associated with a higher risk of death. A rapid change in the rate of change is also a significant event in the absence of prolongation of the QRS interval. Finally, variation in the heart rate is also a marker for sudden death in these patients.^[22]

In other patients, the ECG will reveal atrial tachycardia or atrial fibrillation.

Cardiac catherization

When adults with tetralogy of Fallot (TOF) present, the initial study of choice is usually echocardiography. However, in some cases, cardiac catheterization is needed to assess the pressures in the right ventricle and pulmonary artery, the location and size of the ventricular septal defect, and the status of the pulmonary vessels. Cardiac catheterization is also necessary when the cardiac anatomy cannot be completely defined by echocardiography, when disease in the pulmonary arteries is a concern, and if an anomalous coronary artery or pulmonary hypertension is suspected.

Imaging Studies

Imaging studies used in the evaluation of tetralogy of Fallot (TOF) includechest radiographs, magnetic resonance imaging (MRI), and echocardiography.

Radiography

The chest x-ray may be normal, or it may show cardiomegaly and prominent right ventricular (RV) shadowing. Although the hallmark of tetralogy of Fallot in infants is the classic boot-shaped heart (coeur en sabot) (see the following image), in which diminished vascularity in the lungs and diminished prominence of the pulmonary arteries become apparent, this classic shape of the heart is not always seen in adults with tetralogy of Fallot.

An uplifted apex and absence of pulmonary artery segment typifies the "coeur en sabot" (ie, boot-shaped heart) of tetralogy of Fallot.

View Media Gallery

Echocardiography

Color-flow echocardiography is always obtained in adult patients tetralogy of Fallot to assess the overall cardiac function and the status of the valves, and for the presence of any residual ventricular septal defect (VSD), ductus arterosus, or atrial septal defect. Note that although echocardiography can assess the valvular anatomy, it is unable to visualize the coronary anatomy in the adult patient. This imaging modality is also able to reveal the grade and severity of any RV outflow tract (RVOT) obstruction.

Magnetic resonance imaging

MRI has become the gold standard for assessing the RV function and size, as well as for quantifying the pulmonary regurgitant volume. When a problem with the pulmonary valve is suspected, MRI is the first test of choice. This imaging modality can map the velocity of pulmonary regurgitation and provides good delineation of the aorta size as well as assessment of the pulmonary arteries, the status of the RVOT, and the presence of VSDs and/or RV hypertrophy.^[5] MRI can also measure intracardiac pressures, gradients, and blood flows.

MRI is quite sensitive at detecting branch pulmonary artery stenosis, which may be contributing to the increasing pulmonary valve insufficiency and the formation of aortopulmonary collaterals. These findings are more common in those with tetralogy of Fallot who have pulmonary atresia.^{[23, 24]}

Screening

Some pediatric cardiology centers specialize in looking after patients with tetralogy of Fallot. They recommend a baseline MRI of the the heart, even in the absence of symptoms. The results can then be used to monitor the patient for any changes every 3-7 years.

Treatment & Management

Refaat MM, Ballout J, Mansour M. Ablation of atrial fibrillation in patients with congenital heart disease. Arrhythm Electrophysiol Rev. 2017 Dec. 6 (4):191-4. [Medline].
Maury P, Sacher F, Rollin A, et al. Ventricular arrhythmias and sudden death in tetralogy of Fallot. Arch Cardiovasc Dis. 2017 May. 110 (5):354-62. [Medline].
Fraser CD, Bacha EA, Comas J, Sano S, Sarris GE, Tsang VT. Tetralogy of Fallot. Semin Thorac Cardiovasc Surg. 2015 Summer. 27 (2):189-204. [Medline].
Bhardwaj V, Kapoor PM, Irpachi K, Ladha S, Chowdhury UK. Basic arterial blood gas biomarkers as a predictor of mortality in tetralogy of Fallot patients. Ann Card Anaesth. 2017 Jan-Mar. 20 (1):67-71. [Medline].
Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. 2005 Nov-Dec. 25(6):1535-46. [Medline].
Gabriele B, Maurizio B, Marco B. Does pharmacological therapy still play a role in preventing sudden death in surgically treated tetralogy of Fallot?. Mini Rev Med Chem. 2018. 18 (6):490-4. [Medline].
Faccini A, Micheletti A, Negura DG, et al. Heart failure in grown-up congenital heart disease. Minerva Cardioangiol. 2018 Jun. 66 (3):329-36. [Medline].
Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of Fallot. Cardiol Young. 2005 Feb. 15 Suppl 1:38-47. [Medline].
Sarris GE. Tetralogy surgery - back to Baltimore 70 years later: Melbourne Heritage and Group tribute to Juan Comas. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017 Jan. 20:84-8. [Medline].
Karl TR, Stocker C. Tetralogy of fallot and its variants. Pediatr Crit Care Med. 2016 Aug. 17 (8 suppl 1):S330-6. [Medline].
Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. 2009 Jul-Aug. 28(7-8):809-12. [Medline].
Lee CN, Su YN, Cheng WF, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. 2005 Dec. 84(12):1134-40. [Medline].
Li X, Liu CL, Li XX, Li QC, Ma LM, Liu GL. VEGF gene polymorphisms are associated with risk of tetralogy of Fallot. Med Sci Monit. 2015 Nov 12. 21:3474-82. [Medline].
Anabtawi A, Mondragon J, Dodendorf D, Laskey WK. Late-stage left ventricular dysfunction in adult survivors of tetralogy of Fallot repair in childhood. Open Heart. 2017. 4 (2):e000690. [Medline].
Wu MH, Lu CW, Chen HC, Kao FY, Huang SK. Adult congenital heart disease in a nationwide population 2000-2014: epidemiological trends, arrhythmia, and standardized mortality ratio. J Am Heart Assoc. 2018 Feb 8. 7 (4):[Medline].
Dennis M, Moore B, Kotchetkova I, Pressley L, Cordina R, Celermajer DS. Adults with repaired tetralogy: low mortality but high morbidity up to middle age. Open Heart. 2017. 4 (1):e000564. [Medline].
Rauch R, Hofbeck M, Zweier C, et al. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J Med Genet. 2010 May. 47(5):321-31. [Medline].
Pillutla P, Shetty KD, Foster E. Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005. Am Heart J. 2009 Nov. 158(5):874-9. [Medline].
Diller GP, Kempny A, Liodakis E, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot. Circulation. 2012 May 22. 125(20):2440-6. [Medline].
Chiu SN, Wu MH, Su MJ, et al. Coexisting mutations/polymorphisms of the long QT syndrome genes in patients with repaired Tetralogy of Fallot are associated with the risks of life-threatening events. Hum Genet. 2012 Aug. 131(8):1295-304. [Medline].
Dluzniewska N, Podolec P, Miszalski-Jamka T, et al. Effect of ventricular function and volumes on exercise capacity in adults with repaired Tetralogy of Fallot. Indian Heart J. 2018 Jan - Feb. 70 (1):87-92. [Medline].
Vehmeijer JT, Koyak Z, Bokma JP, et al. Sudden cardiac death in adults with congenital heart disease: does QRS-complex fragmentation discriminate in structurally abnormal hearts?. Europace. 2018 Jun 1. 20 (FI1):f122-8. [Medline].
Gaydos SS, Varga-Szemes A, Judd RN, Suranyi P, Gregg D. Imaging in adult congenital heart disease. J Thorac Imaging. 2017 Jul. 32 (4):205-16. [Medline].
Bokma JP, de Wilde KC, Vliegen HW, et al. Value of cardiovascular magnetic resonance imaging in noninvasive risk stratification in tetralogy of Fallot. JAMA Cardiol. 2017 Jun 1. 2 (6):678-83. [Medline].
Scalone G, Gomez-Monterrosas O, Fiszer R, Szkutnik M, Galeczka M, Bialkowski J. Combined strategy of Waterston shunt percutaneous occlusion and medical treatment with sildenafil for management of pulmonary hypertension in an adult patient with corrected tetralogy of Fallot. Postepy Kardiol Interwencyjnej. 2017. 13 (3):277-8. [Medline].
McRae ME, Coleman B, Atz TW, Kelechi TJ. Patient outcomes after transcatheter and surgical pulmonary valve replacement for pulmonary regurgitation in patients with repaired tetralogy of Fallot: A quasi-meta-analysis. Eur J Cardiovasc Nurs. 2017 Aug. 16 (6):539-53. [Medline].
Bhagra CJ, Hickey EJ, Van De Bruaene A, Roche SL, Horlick EM, Wald RM. Pulmonary valve procedures late after repair of tetralogy of Fallot: current perspectives and contemporary approaches to management. Can J Cardiol. 2017 Sep. 33 (9):1138-49. [Medline].
Pragt H, van Melle JP, Javadikasgari H, et al. Mechanical valves in the pulmonary position: an international retrospective analysis. J Thorac Cardiovasc Surg. 2017 Oct. 154 (4):1371-8.e1. [Medline].
Therrien J, Marx GR, Gatzoulis MA. Late problems in tetralogy of Fallot--recognition, management, and prevention. Cardiol Clin. 2002 Aug. 20 (3):395-404. [Medline].
Ezzat VA, Ryan MJ, O'Leary J, et al. Radiofrequency ablation of atrial tachyarrhythmias in adults with tetralogy of Fallot - predictors of success and outcome. Cardiol Young. 2017 Mar. 27 (2):284-93. [Medline].
Davidson J, Tong S, Hancock H, Hauck A, da Cruz E, Kaufman J. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery. Intensive Care Med. 2012 Jul. 38(7):1184-90. [Medline].
Menting ME, van den Bosch AE, McGhie JS, et al. Assessment of ventricular function in adults with repaired Tetralogy of Fallot using myocardial deformation imaging. Eur Heart J Cardiovasc Imaging. 2015 Dec. 16(12):1347-57. [Medline].
Lindsey CW, Parks WJ, Kogon BE, Sallee D 3rd, Mahle WT. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg. 2010 Jan. 89(1):147-51. [Medline].
Bokma JP, Geva T, Sleeper LA, et al. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018 May. 104 (9):738-44. [Medline].
Heng EL, Gatzoulis MA, Uebing A, et al. Immediate and midterm cardiac remodeling after surgical pulmonary Vvalve replacement in adults with repaired tetralogy of Fallot: a prospective cardiovascular magnetic resonance and clinical study. Circulation. 2017 Oct 31. 136 (18):1703-13. [Medline].
Mitropoulos FM, Kanakis MA, Ntellos C, et al. Pulmonary valve replacement in patients with corrected tetralogy of Fallot. J Cardiovasc Thorac Res. 2017. 9 (2):71-7. [Medline].
Caruana M, Grech V. A first population-based long-term outcome study in adults with repaired tetralogy of Fallot in Malta. Congenit Heart Dis. 2017 May. 12 (3):301-8. [Medline].
Kanter KR, Kogon BE, Kirshbom PM, Carlock PR. Symptomatic neonatal tetralogy of Fallot: repair or shunt?. Ann Thorac Surg. 2010 Mar. 89(3):858-63. [Medline].
Tsang FH, Li X, Cheung YF, Chau KT, Cheng LC. Pulmonary valve replacement after surgical repair of tetralogy of Fallot. Hong Kong Med J. 2010 Feb. 16(1):26-30. [Medline].
Alkashkari W, Alsubei A, Hijazi ZM. Transcatheter pulmonary valve replacement: current state of art. Curr Cardiol Rep. 2018 Mar 15. 20 (4):27. [Medline].
Jones MI, Qureshi SA. Recent advances in transcatheter management of pulmonary regurgitation after surgical repair of tetralogy of Fallot. F1000Res. 2018. 7:[Medline].
Plessis J, Hascoet S, Baruteau A, et al. Edwards SAPIEN transcatheter pulmonary valve implantation: results from a French registry. JACC Cardiovasc Interv. 2018 Oct 8. 11 (19):1909-16. [Medline].
[Guideline] Cotts TB. 2018 AHA/ACC guideline for adults with congenital heart disease. American College of Cardiology. Available at https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2018/08/13/16/26/2018-aha-acc-guideline-for-the-management-of-achd. August 16, 2018; Accessed: October 25, 2018.
Senzaki H, Ishido H, Iwamoto Y, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). 2008 Jul-Aug. 84(4):377-80. [Medline].
Rodan L, McCrindle BW, Manlhiot C, et al. Stroke recurrence in children with congenital heart disease. Ann Neurol. 2012 Jul. 72(1):103-11. [Medline].
Tanel RE. ECGs in the ED. Pediatr Emerg Care. 2007 Jun. 23(6):428-9. [Medline].
[Guideline] Witte KK, Pepper CB, Cowan JC, Thomson JD, English KM, Blackburn ME. Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot. Europace. 2008 Aug. 10(8):926-30. [Medline].
Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008 Jan 22. 117(3):363-70. [Medline].
Chrysostomou C, Sanchez De Toledo J, Avolio T, et al. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery?. Pediatr Crit Care Med. 2009 Nov. 10(6):654-60. [Medline].
Shepard SM, Tejman-Yarden S, Khanna S, Davis CK, Batra AS. Dexmedetomidine-related atrial standstill and loss of capture in a pediatric patient after congenital heart surgery. Crit Care Med. 2011 Jan. 39(1):187-9. [Medline].
Al Habib HF, Jacobs JP, Mavroudis C, et al. Contemporary patterns of management of tetralogy of Fallot: data from the Society of Thoracic Surgeons Database. Ann Thorac Surg. 2010 Sep. 90(3):813-9; discussion 819-20. [Medline].
Gustafson RA, Murray GF, Warden HE, Hill RC, Rozar GE Jr. Early primary repair of tetralogy of Fallot. Ann Thorac Surg. 1988 Mar. 45(3):235-41. [Medline].
Park CS, Lee JR, Lim HG, Kim WH, Kim YJ. The long-term result of total repair for tetralogy of Fallot. Eur J Cardiothorac Surg. 2010 Sep. 38(3):311-7. [Medline].
Robinson JD, Rathod RH, Brown DW, et al. The evolving role of intraoperative balloon pulmonary valvuloplasty in valve-sparing repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2011 Dec. 142(6):1367-73. [Medline].
Pacifico AD, Kirklin JK, Colvin EV, McConnell ME, Kirklin JW. Transatrial-transpulmonary repair of tetralogy of Fallot. Semin Thorac Cardiovasc Surg. 1990 Jan. 2(1):76-82. [Medline].
Yao Q, Hu XH, Shen QL, et al. Differential effect of the ratio of right ventricular volume to left ventricular volume in children with repaired tetralogy of Fallot. Cardiology. 2016. 133(3):135-40. [Medline].
Aboulhosn J, Child JS. Management after childhood repair of tetralogy of fallot. Curr Treat Options Cardiovasc Med. 2006 Dec. 8(6):474-83. [Medline].
Devore GR, Polanko B. Tomographic ultrasound imaging of the fetal heart: a new technique for identifying normal and abnormal cardiac anatomy. J Ultrasound Med. 2005 Dec. 24(12):1685-96. [Medline].
Duro RP, Moura C, Leite-Moreira A. Anatomophysiologic basis of tetralogy of Fallot and its clinical implications. Rev Port Cardiol. 2010 Apr. 29(4):591-630. [Medline].
Fox D, Devendra GP, Hart SA, Krasuski RA. When 'blue babies' grow up: What you need to know about tetralogy of Fallot. Cleve Clin J Med. 2010 Nov. 77 (11):821-8. [Medline].
He GW. Current strategy of repair of tetralogy of Fallot in children and adults: emphasis on a new technique to create a monocusp-patch for reconstruction of the right ventricular outflow tract. J Card Surg. 2008 Nov-Dec. 23 (6):592-9. [Medline].
Horer J, Friebe J, Schreiber C, et al. Correction of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in adults. Ann Thorac Surg. 2005 Dec. 80 (6):2285-91. [Medline].
Hovels-Gurich HH, Konrad K, Skorzenski D, et al. Long-term behavior and quality of life after corrective cardiac surgery in infancy for tetralogy of Fallot or ventricular septal defect. Pediatr Cardiol. 2007 Sep-Oct. 28 (5):346-54. [Medline].
Kantorova A, Zbieranek K, Sauer H, Lilje C, Haun C, Hraska V. Primary early correction of tetralogy of Fallot irrespective of age. Cardiol Young. 2008 Apr. 18 (2):153-7. [Medline].
Laidman J. Fluconazole linked to increased risk for rare birth defect. Medscape Medical News from WebMD. August 28, 2013. Available at http://www.medscape.com/viewarticle/810149. Accessed: September 5, 2013.
Miatton M, De Wolf D, François K, Thiery E, Vingerhoets G. Intellectual, neuropsychological, and behavioral functioning in children with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2007 Feb. 133 (2):449-55. [Medline].
Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med. 2013 Aug 29. 369 (9):830-9. [Medline].
Patel CR, Agamanolis DP, Stewart JW. Prenatal diagnosis of tetralogy of Fallot with obstructed supracardiac totally anomalous pulmonary venous connection. Cardiol Young. 2005 Dec. 15 (6):656-9. [Medline].
Redington AN. Determinants and assessment of pulmonary regurgitation in tetralogy of Fallot: practice and pitfalls. Cardiol Clin. 2006 Nov. 24 (4):631-9, vii. [Medline].
Sakamoto T, Nagase Y, Hasegawa H, Shin'oka T, Tomimatsu H, Kurosawa H. One-stage intracardiac repair in combination with external stenting of the trachea and right bronchus for tetralogy of Fallot with an absent pulmonary valve and tracheobronchomalacia. J Thorac Cardiovasc Surg. 2005 Dec. 130 (6):1717-8. [Medline].
Srivastava S, Salem Y, Chatterjee S, et al. Echocardiographic myocardial deformation evaluation of right ventricular function in comparison with CMRI in repaired tetralogy of Fallot: a cross-sectional and longitudinal validation study. Echocardiography. 2013 Feb. 30 (2):196-202. [Medline].
Starr JP. Tetralogy of Fallot: yesterday and today. World J Surg. 2010 Apr. 34 (4):658-68. [Medline].
Aguayo-Gomez A, Arteaga-Vazquez J, Svyryd Y, et al. Identification of copy number variations in isolated tetralogy of Fallot. Pediatr Cardiol. 2015 Dec. 36 (8):1642-6. [Medline].
Shahanavaz S, Qureshi AM, Levi DS, et al. Transcatheter pulmonary valve replacement with the Melody valve in small diameter expandable right ventricular outflow tract conduits. JACC Cardiovasc Interv. 2018 Mar 26. 11 (6):554-64. [Medline].
Naidu P, Grigg L, Zentner D. Mortality in adults with congenital heart disease. Int J Cardiol. 2017 Oct 15. 245:125-30. [Medline].
Apostolopoulou SC, Vagenakis G, Rammos S. Pulmonary vasodilator therapy in tetralogy of Fallot with pulmonary atresia and major aortopulmonary collaterals: case series and review of literature. Cardiol Young. 2017 Nov. 27 (9):1861-4. [Medline].
[Guideline] Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Aug 10. [Medline]. [Full Text].
Kwak JG, Kim WH, Kim ER, Lim JH, Min J. One-year follow-up after tetralogy of Fallot total repair preserving pulmonary valve and avoiding right ventriculotomy. Circ J. 2018 Oct 5. [Medline].

Media Gallery

Anatomic findings in tetralogy of Fallot are depicted.
This is a typical preoperative electrocardiogram (ECG) for tetralogy of Fallot.
Typical findings on postoperative electrocardiogram (ECG) for tetralogy of Fallot are shown.
An uplifted apex and absence of pulmonary artery segment typifies the "coeur en sabot" (ie, boot-shaped heart) of tetralogy of Fallot.
This angiogram shows a catheter in the right ventricle—severe infundibular stenosis.
This image shows completed blocking with a Taussig shunt.
An opening in the right ventricle exposes the ventricular septal defect.
Interrupted pledgetted sutures are used to close a ventricular septal defect.
This image shows a closed ventricular septal defect and closure of right ventriculotomy with Gore-Tex.
Gore-Tex is used for complete closure of right ventriculotomy.
Melody pulmonary valve.

of 11

Author

Shabir Bhimji, MD, PhD Cardiothoracic and Vascular Surgeon, Saudi Arabia and Middle East Hospitals

Shabir Bhimji, MD, PhD is a member of the following medical societies: American Cancer Society, American College of Chest Physicians, American Lung Association, Texas Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Mary C Mancini, MD, PhD, MMM Surgeon-in-Chief and Director of Cardiothoracic Surgery, Christus Highland

Mary C Mancini, MD, PhD, MMM is a member of the following medical societies: American Association for Thoracic Surgery, American College of Surgeons, American Surgical Association, Phi Beta Kappa, Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Chief Editor

Yasmine S Ali, MD, FACC, FACP, MSCI President, Nashville Preventive Cardiology, PLLC; Assistant Clinical Professor of Medicine, Vanderbilt University School of Medicine

Yasmine S Ali, MD, FACC, FACP, MSCI is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, National Lipid Association, Tennessee Medical Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: MCG Health, LLC.

Acknowledgements

David FM Brown, MD Associate Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital

David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: lippincott Royalty textbook royalty; wiley Royalty textbook royalty

David A Donson, MD Assistant Medical Director, Department of Emergency Medicine, Maimonides Medical Center

David A Donson, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Theodore J Gaeta, DO, MPH, FACEP Clinical Associate Professor, Department of Emergency Medicine, Weill Cornell Medical College; Vice Chairman and Program Director of Emergency Medicine Residency Program, Department of Emergency Medicine, New York Methodist Hospital; Academic Chair, Adjunct Professor, Department of Emergency Medicine, St George's University School of Medicine

Theodore J Gaeta, DO, MPH, FACEP is a member of the following medical societies: Alliance for Clinical Education, American College of Emergency Physicians, Clerkship Directors in Emergency Medicine, Council of Emergency Medicine Residency Directors, New York Academy of Medicine, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Ronald J Oudiz, MD, FACP, FACC, FCCP Professor of Medicine, University of California, Los Angeles, David Geffen School of Medicine; Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, LA Biomedical Research Institute at Harbor-UCLA Medical Center

Ronald J Oudiz, MD, FACP, FACC, FCCP is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physicians, American Heart Association, and American Thoracic Society

Disclosure: Actelion Grant/research funds Clinical Trials + honoraria; Ikaria Grant/research funds Clinical Trials + honoraria; Gilead Grant/research funds Clinical Trials + honoraria; Pfizer Grant/research funds Clinical Trials + honoraria; United Therapeutics Grant/research funds Clinical Trials + honoraria; Lilly Grant/research funds Clinical Trials + honoraria; Lung LLC Clinical Trials + honoraria; Bayer Grant/research funds Consulting; Medtronic Consulting fee Consulting; Novartis Consulting fee Consulting

Kurt Pflieger, MD, FAAP Active Staff, Department of Pediatrics, Lake Pointe Medical Center

Kurt Pflieger, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Gary Edward Sander, MD, PhD, FACC, FAHA, FACP, FASH Professor of Medicine, Director of CME Programs, Team Leader, Root Cause Analysis, Tulane University Heart and Vascular Institute; Director of In-Patient Cardiology, Tulane Service, University Hospital; Visiting Physician, Medical Center of Louisiana at New Orleans; Faculty, Pennington Biomedical Research Institute, Louisiana State University; Professor, Tulane University School of Medicine

Gary Edward Sander, MD, PhD, FACC, FAHA, FACP, FASH is a member of the following medical societies: Alpha Omega Alpha, American Chemical Society, American College of Cardiology, American College of Chest Physicians, American College of Physicians, American Federation for Clinical Research, American Federation for Medical Research, American Heart Association, American Society for Pharmacology and Experimental Therapeutics, American Society of Hypertension,American Thoracic Society, Heart Failure Society of America, Louisiana State Medical Society, National Lipid Association, and Southern Society for Clinical Investigation

Disclosure: Forest Labs Honoraria Speaking and teaching

Gary Setnik, MD Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School

Gary Setnik, MD is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine

Disclosure: SironaHealth Salary Management position; South Middlesex EMS Consortium Salary Management position; ProceduresConsult.com Royalty Other

Mark Spektor, DO Medical Director, Department of Emergency Medicine, Maimonides Medical Center

Mark Spektor, DO is a member of the following medical societies: American College of Emergency Physicians, American College of Physician Executives, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Sections Tetralogy of Fallot (TOF) in Adults
Overview
Presentation
DDx
Workup
Treatment
Guidelines
Medication
Questions & Answers
Media Gallery
References

Tetralogy of Fallot (TOF) in Adults Workup

Approach Considerations

Laboratory studies

Electrocardiography

Cardiac catherization

Imaging Studies

Radiography

Echocardiography

Magnetic resonance imaging

About

Membership

Apps

WebMD Network

Editions

What to Read Next on Medscape

Tetralogy of Fallot (TOF) in Adults Workup

Approach Considerations

Laboratory studies

Electrocardiography

Cardiac catherization

Imaging Studies

Radiography

Echocardiography

Magnetic resonance imaging

References

Tables

Contributor Information and Disclosures

What would you like to print?

Find Us On

About

Membership

Apps

WebMD Network

Editions

What to Read Next on Medscape

Related Conditions and Diseases

Medscape Consult

News & Perspective

Tools

Slideshow

Most Popular Articles

Recommended